Wound Healing Product Articles & Analysis
22 news found
These hydrogels are pivotal in medical devices, regenerative medicine, drug delivery systems, 3D cell culture, and wound healing." Diverse Product Offering: Biopharma PEG’s multi-arm PEG products are available with various branching structures and functional groups to meet the specific needs of researchers and developers in ...
(OTCQB:SNWV), a leading provider of next-generation wound care products and its JV partner Diversa S.A. have announced a new distribution agreement with Grupo Suprimed to market and sell the dermaPACE® System in the private healthcare market in Brazil. ...
(SNWV), a leading provider of next-generation wound care products, today announced three new board members will join as one departs. ...
(SNWV), a leading provider of next-generation wound care products, has announced they will be updating shareholders on a monthly basis during 2022 with regards to their Sales Funnel and System Trials. ...
The “Sport of Life” initiative aims to promote awareness about sports injuries and provide treatment for sportspeople. As a part of this initiative, Healthium will aid in the treatment of sports injuries with free arthroscopy implants. Bhaichung Bhutia, torchbearer of Indian Football in the international arena, Abhinav Bindra, India's first Individual Olympic gold medalist and ...
Aurealis Therapeutics, a synthetic biology company developing ground-breaking four-in-one cell and gene therapies, announced today the publication of the first study on its investigational product AUP-16, a four-in-one -combination therapy using live Lactococcus lactis expressing three human therapeutic proteins for the treatment of chronic non-healing ...
Axio Biosolutions, a pioneering MedTech company, today announced a $6 million Series B2 equity raise led by TrueScale Capital, with participation from existing investors Omidyar Network India, University of California– Ratan Tata Fund, and Accel. Axio Biosolutions Private Limited, India (“Axio”), a wholly owned subsidiary of Boston-based Advamedica Inc. is a leading developer of ...
Imbed Biosciences is proud to announce that its animal health product, MicroLyte® Vet, is now available in Canada through McCarthy and Sons Service. McCarthy & Sons Service is a full-service veterinary marketing, supply, and distribution company. Their team of distribution representatives are well versed in surgical and wound care products, and has experience bringing ...
MediPurpose announced today that it has signed an agreement with Vizient to offer SurgiLance™ Safety Lancets to all Vizient members at contracted pricing. Vizient is the largest member-driven healthcare performance improvement company in the US, providing solutions and services that improve the delivery of high-value care by aligning cost, quality and market performance for more than 50% ...
(OTCQB: SNWV), focused on the development and commercialization of a robust and innovative advanced wound care product portfolio for the repair and regeneration of skin and vascular structures, today announced its rebranding. ...
(OTCQB: SNWV), focused on the development and commercialization of a robust and innovative advanced wound care product portfolio for the repair and regeneration of skin and vascular structures, announced today that the Company has entered into a non-exclusive sales and marketing agreement with Ametus to market and sell the Company’s portfolio of ...
Marizyme, Inc. (OTCQB:MRZM), a publicly traded global biotechnology company developing products to reduce the burden of ischemia-reperfusion injury in tissue grafting, organ transplant, and other surgical indications, announced today that it has added two life science industry veterans to its senior management team. Roger Schaller has been appointed Executive Vice President (EVP) of Commercial ...
Atlanta, GA and Charlotte, TN – MediPurpose announced today that it signed an agreement with Premier Inc to include SurgiLance™ Safety Lancets. Premier GPO members have been able to purchase SurgiLance™ Safety Lancets since 1 Dec 2018. “MediPurpose has been selling SurgiLance™ Safety Lancets for 20 years. We are excited with this new partnership with Premier and ...
Northern Ireland headquartered Eakin Healthcare Group has announced it is expanding into a new therapeutic area with the acquisition of Coleraine based Armstrong Medical, which specialises in respiratory care products. The deal represents a diversification for the Group which to date has specialised in ostomy and wound care products. The combined resources of the two indigenous NI healthcare ...
AVA Scientific Meeting 2019 highlights key opportunities for improvement in vascular access from process bundles to emerging new products Introduction Acknowledgment of the importance of the vascular access nurse and team were obvious at this year’s Association for Vascular Access (AVA) Annual Scientific meeting. When Ramzy Nasrallah took over as CEO for the Association of Vascular Access ...
In partnership with Mesoblast Limited, JCR Pharmaceuticals has filed to extend the marketing approval of TEMCELL, a mesenchymal stem cell (MSC) wound healing product for patients with Epidermolysis Bullosa (EB). ...
ByIMAPAC
MediPurpose™, a manufacturer and master distributor of medical products, today announced that DS Medical is now an authorized distributor of MediPurpose, Inc for SurgiLance Safety Lancets in United Kingdom effective immediately. “We are pleased to continue serving our UK customers through DS Medical,” said Patrick Yi, CEO of MediPurpose. Richard Bourke, Managing Director of DS ...
ReShape Lifesciences Inc. (NASDAQ:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced an exclusive federal government business channel sales agreement with Academy Medical, LLC to sell its ReShape Balloon™ and ReShape vBloc products to U.S. Department of Defense (DoD) medical facilities. Through this agreement, the ReShape ...
MediPurpose™, a manufacturer and master distributor of medical products, today announced that Smiths Medical is no longer an authorized distributor of MediPurpose, Inc for SurgiLance safety lancets effective immediately. If you are a distributor or hospital in the United Kingdom and wish to make a purchase, please visit DS Medical’s website (https://www.dsmedical.co.uk/) for more ...
(OTCQB: BLGO) subsidiary Clyra Medical Technologies, Inc. has successfully concluded a financing from Sanatio Capital LLC for $750,000 in equity and a forward commitment to provide a $5,000,000 operating line of credit, to support the FDA approval and commercial launch of Clyra's advanced wound care products. Clyra Medical Technologies holds the exclusive ...